Literature DB >> 17827789

Activin A: autocrine regulator of kidney development and repair.

Akito Maeshima1, Masaaki Miya, Keiichiro Mishima, Shin Yamashita, Itaru Kojima, Yoshihisa Nojima.   

Abstract

The research described in this review suggests a novel and important role for activin A in the developmental and repair processes of the kidney (Table 1). The results obtained in these studies indicate that activin A is a negative regulator of kidney development and plays an essential part in kidney diseases, such as acute renal failure or renal fibrosis. It is also possible that activin A is a key player in the pathophysiological processes of other kidney diseases, such as congenital urogenital abnormalities, renal cystic disease and renal cell carcinoma. Activin A is thus a potential target for therapeutic interventions in kidney diseases. To address this issue, more detailed analysis on the regulation of activin production, modulation of activin activity and activin target genes is required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827789     DOI: 10.1507/endocrj.kr-113

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  11 in total

1.  Blockade of ALK4/5 signaling suppresses cadmium- and erastin-induced cell death in renal proximal tubular epithelial cells via distinct signaling mechanisms.

Authors:  Kota Fujiki; Hisako Inamura; Takeshi Sugaya; Masato Matsuoka
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

2.  Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation.

Authors:  Zhenhua Wang; Ning Zhang; Ruifeng Song; Ruitai Fan; Liuqin Yang; Liping Wu
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

3.  Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.

Authors:  Olga A Agapova; Yifu Fang; Toshifumi Sugatani; Michael E Seifert; Keith A Hruska
Journal:  Kidney Int       Date:  2016-03-11       Impact factor: 10.612

4.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

5.  Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.

Authors:  Seung-Beom Hong; HyoungBin Oh; Vladimir A Valera; Jaime Stull; Duy-Tan Ngo; Masaya Baba; Maria J Merino; W Marston Linehan; Laura S Schmidt
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

6.  Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.

Authors:  Hirono Iriuchishima; Akito Maeshima; Shunsuke Takahashi; Takuma Ishizaki; Akihiko Yokohama; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa
Journal:  Biosci Rep       Date:  2019-05-31       Impact factor: 3.840

7.  Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.

Authors:  Anders Nordholm; Søren Egstrand; Eva Gravesen; Maria L Mace; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Pflugers Arch       Date:  2019-06-24       Impact factor: 3.657

Review 8.  Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy.

Authors:  Akito Maeshima; Masao Nakasatomi; Yoshihisa Nojima
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

9.  Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.

Authors:  Akito Maeshima; Keiichiro Mishima; Shin Yamashita; Masao Nakasatomi; Masaaki Miya; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Keiju Hiromura; Yoshihisa Hasegawa; Itaru Kojima; Yoshihisa Nojima
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

10.  Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.

Authors:  Shunsuke Takahashi; Masao Nakasatomi; Yoshinori Takei; Hidekazu Ikeuchi; Toru Sakairi; Yoriaki Kaneko; Keiju Hiromura; Yoshihisa Nojima; Akito Maeshima
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.